Bryce Point Capital’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,550
Closed -$419K 260
2024
Q4
$419K Buy
+20,550
New +$419K 0.12% 379